Long-Term Results of 2-Dimensional Radiation Therapy in Patients with Nasopharyngeal Cancer
![]() |
Lee, Nam-Kwon
(Department of Radiation Oncology, Korea University College of Medicine)
Park, Young-Je (Department of Radiation Oncology, Korea University College of Medicine) Yang, Dae-Sik (Department of Radiation Oncology, Korea University College of Medicine) Yoon, Won-Sup (Department of Radiation Oncology, Korea University College of Medicine) Lee, Suk (Department of Radiation Oncology, Korea University College of Medicine) Kim, Chul-Yong (Department of Radiation Oncology, Korea University College of Medicine) |
1 | Chan AT, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005;97:536-539 DOI ScienceOn |
2 | Waldron J, Tin MM, Keller A, et al. Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiother Oncol 2003;68:153-161 DOI ScienceOn |
3 | Chan SH, Ng WT, Kam KL, et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys 2009;73:1335-1342 DOI ScienceOn |
4 | Lee SH, Kim TH, Chie EK, et al. Evaluation of xerostomia following intensity modulated radiotherapy (lMRT) for head and neck cancer patients. J Korean Soc Ther Radiol Oncol 2004;22:106-114 과학기술학회마을 |
5 | Sumitsawan Y, Chaiyasate S, Chitapanarux I, et al. Late complications of radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx 2009;36:205-209 DOI ScienceOn |
6 | Ayan I, Kaytan E, Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol 2003;4:13-21 DOI ScienceOn |
7 | Teo P, Yu P, Lee WY, et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 1996;36:291-304 |
8 | Farias TP, Dias FL, Lima RA, et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:794-799 DOI ScienceOn |
9 | Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 2005;62:672-679 DOI ScienceOn |
10 | Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704 DOI ScienceOn |
11 | Chen E, Winquist E, Agulnik M, et al. A phase II study of Sorafenib (BAY 43-9006) in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC). Eur J Cancer Suppl 2005;3:297 |
12 | Bar-Sela G, Ben Arush MW, Sabo E, Kuten A, Minkov I, Ben-Izhak O. Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults. Pediatr Blood Cancer 2005:45:291-297 DOI ScienceOn |
13 | Chen CY, Han F, Zhao C, et al. Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone. Br J Radiol 2009;82:452-458 DOI ScienceOn |
14 | Chan AT, Ma B, Hui EP, et al. Phase II study of gefitinib in metastatic or locoregionally recurrent nasopharyngeal carcinoma (NPC). J Clin Oncol 2006;24(18 Suppl):15509 |
15 | Lin S, Lu JJ , Han L, Chen Q, Pan J. Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC Cancer 2010;10:39 DOI |
16 | Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22 DOI ScienceOn |
17 | Leibel SA, Kutcher GJ, Harrison LB, et al. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1991;20:823-833 DOI ScienceOn |
18 | Wadsley JC, Bentzen SM. Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;60:1405-1409 DOI ScienceOn |
19 | Chan AT, Hsu MM, Goh BC, et al. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol 2005;23:3568-3576 DOI ScienceOn |
20 | Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (lMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006;64:57-62 DOI ScienceOn |
21 | AI-Saraf M, LeBlanc M, Giri PG, et al. Superiority of five year survival with chemo-radiotherapy (CT-RT) vs radiotherapy in patients (Pts) with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III Study: Final Report (abstract #905). Proc Am Soc Clin Oncol 2001;20:227a |
22 | Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials. Am J Clin Oncol 2002;25:219-223 DOI ScienceOn |
23 | Zhang L, Zhao C, Ghimire BR, Guo Y, Guan ZZ. The role of concurrent chemoradiation in the treatment of locally advanced nasopharyngeal carcinoma among endemic area: a meta-analysis of the phase III randomized trials. J Clin Oncol 2008;26(15 Suppl):6032 DOI |
24 | Kwong DL, Sham JS, Leung LH, et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal cacinoma. Int J Radiat Oncol Biol Phys 2006;64:374-381 DOI ScienceOn |
25 | AI-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317 |
26 | Tang L, Mao Y, Liu L. et al. The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer 2009;115:680-688 DOI ScienceOn |
27 | Lin JC, Jan JS , Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-637 DOI ScienceOn |
28 | Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005;23:6730-6738 DOI ScienceOn |
29 | Lee AW, Lau WH, Tung SY, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 2005;23:6966-6975 DOI ScienceOn |
30 | Chen Y, Liu MZ, Liang SB, et al. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Int J Radiat Oncol Biol Phys 2008;71:1356-1364 DOI ScienceOn |
31 | Ng WT, Lee AW, Kan WK, et al. N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels. Radiother Oncol 2007;82:70-75 DOI ScienceOn |
32 | Lee AW, Perez CA, Law SCK, et al. Nasopharynx. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. 5th ed, Philadelphia: Lippincott Co., 2009:820-854 |
33 | Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence (2005) and surival (1993-2005) in Korea. Seoul: Ministry for Health, Welfare and Family Affairs, 2008:36-37 |
34 | Lee AW, Foo W, Law SC. et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J 1997;3:355-361 |
![]() |